Phase 3 Open-Label Study Evaluating the Efficacy and Safety of Mavacamten in Japanese Adults With Obstructive Hypertrophic Cardiomyopathy - The HORIZON-HCM Study.
Kitaoka H, Ieda M, Ebato M, Kozuma K, Takayama M, Tanno K, Komiyama N, Sakata Y, Maekawa Y, Minami Y, Ogimoto A, Takaya T, Yasuda S, Amiya E, Furukawa Y, Watanabe T, Hiraya D, Miyagoshi H, Kinoshita G, Reedy A, Hegde SM, Florea V, Izumi C.
Kitaoka H, et al. Among authors: yasuda s.
Circ J. 2024 Nov 7. doi: 10.1253/circj.CJ-24-0501. Online ahead of print.
Circ J. 2024.
PMID: 39505542
Free article.